Evidence-Based Tuberculosis Diagnosis
article has not abstract
Vyšlo v časopise:
Evidence-Based Tuberculosis Diagnosis. PLoS Med 5(7): e156. doi:10.1371/journal.pmed.0050156
Kategorie:
Research in Translation
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.0050156
Souhrn
article has not abstract
Zdroje
1. Stop TB Partnership, World Health Organization
2006
The global plan to stop TB 2006–2015.
Available: http://www.stoptb.org/globalplan/. Accessed 16 June 2008
2. RaviglioneMCUplekarMW
2006
WHO's new Stop TB Strategy.
Lancet
367
952
955
3. World Health Organization
2007
New technologies for tuberculosis control: A framework for their adoption, introduction and implementation.
Available: http://whqlibdoc.who.int/publications/2007/9789241595520_eng.pdf. Accessed 16 June 2008
4. World Health Organization, Special Programme for Research and Training in Tropical Diseases
2006
Diagnostics for tuberculosis. Global demand and market potential.
Available: http://www.who.int/tdr/publications/publications/tbdi.htm. Accessed 16 June 2008
5. OxmanADLavisJNFretheimA
2007
Use of evidence in WHO recommendations.
Lancet
369
1883
1889
6. HillSPangT
2007
Leading by example: A culture change at WHO.
Lancet
369
1842
1844
7. World Health Organization
2008
Moving research findings into new WHO policies.
Available: http://www.who.int/tb/dots/laboratory/policy/en/index4.html. Accessed 16 June 2008
8. PaiMMcCullochMEnanoriaWColfordJMJr
2004
Systematic reviews of diagnostic test evaluations: What's behind the scenes.
ACP J Club
141
A11
A13
9. DaleyPThomasSPaiM
2007
Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: A systematic review.
Int J Tuberc Lung Dis
11
1166
1176
10. DinnesJDeeksJKunstHGibsonACumminsE
2007
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.
Health Technol Assess
11
1
196
11. FloresLLPaiMColfordJMJrRileyLW
2005
In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression.
BMC Microbiol
5
55
12. GotoMNoguchiYKoyamaHHiraKShimboT
2003
Diagnostic value of adenosine deaminase in tuberculous pleural effusion: A meta-analysis.
Ann Clin Biochem
40
374
381
13. GrecoSGirardiEMasciangeloRCapoccettaGBSaltiniC
2003
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: A meta-analysis.
Int J Tuberc Lung Dis
7
777
786
14. GrecoSGirardiENavarraSSaltiniC
2006
The current evidence on diagnostic accuracy of commercial based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.
Thorax
61
783
790
15. JiangJShiHZLiangQL
2007
Diagnostic value of interferon-g in tuberculous pleurisy: A meta-analysis.
Chest
131
1133
1141
16. KalantriSPaiMPascopellaLRileyLReingoldA
2005
Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: A systematic review and meta- analysis.
BMC Infect Dis
5
59
17. LiangQLShiHZWangKQinSMQinXJ
2008
Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: A meta-analysis.
Respir Med
102
744
754
18. LingDIFloresLLRileyLWPaiM
2008
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: Meta-analysis and meta-regression.
PLoS ONE
3
e1536
doi:10.1371/journal.pone.0001536
19. MartinAPortaelsFPalominoJC
2007
Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis.
J Antimicrob Chemother
59
175
183
20. MaseSRRamsayANgVHenryMHopewellPC
2007
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: A systematic review.
Int J Tuberc Lung Dis
11
485
495
21. MenziesDPaiMComstockG
2007
Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research.
Ann Intern Med
146
340
354
22. MorganMKalantriSFloresLPaiM
2005
A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis.
BMC Infect Dis
5
62
23. PaiMFloresLLHubbardARileyLWColfordJMJr
2004
Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: A systematic review and meta-analysis.
BMC Infect Dis
4
6
24. PaiMFloresLLPaiNHubbardARileyLW
2003
Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: A systematic review and meta-analysis.
Lancet Infect Dis
3
633
643
25. PaiMKalantriSPascopellaLRileyLWReingoldAL
2005
Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: A meta-analysis.
J Infect
51
175
187
26. PaiMRileyLWColfordJMJr
2004
Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review.
Lancet Infect Dis
4
761
776
27. RiquelmeACalvoMSalechFValderramaSPattilloA
2006
Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis: A meta-analysis.
J Clin Gastroenterol
40
705
710
28. SarmientoOLWeigleKAAlexanderJWeberDJMillerWC
2003
Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis.
J Clin Microbiol
41
3233
3240
29. SteingartKRHenryMLaalSHopewellPCRamsayA
2007
A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis.
Thorax
62
911
918
30. SteingartKRHenryMLaalSHopewellPCRamsayA
2007
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: A systematic review.
PLoS Med
4
e202
doi:10.1371/journal.pmed.0040202
31. SteingartKRHenryMNgVHopewellPCRamsayA
2006
Fluorescence versus conventional sputum smear microscopy for tuberculosis: A systematic review.
Lancet Infect Dis
6
570
581
32. SteingartKRNgVHenryMHopewellPCRamsayA
2006
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: A systematic review.
Lancet Infect Dis
6
664
674
33. TuonFFLitvocMNLopesMI
2006
Adenosine deaminase and tuberculous pericarditis—A systematic review with meta-analysis.
Acta Trop
99
67
74
34. WangLTurnerMOElwoodRKSchulzerMFitzGeraldJM
2002
A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements.
Thorax
57
804
809
35. FarhatMGreenawayCPaiMMenziesD
2006
False-positive tuberculin skin tests: What is the absolute effect of BCG and non-tuberculous mycobacteria.
Int J Tuberc Lung Dis
10
1192
1204
36. MartinAPanaiotovSPortaelsFHoffnerSPalominoJC
2008
The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: A systematic review and meta-analysis.
J Antimicrob Chemother
62
56
64
37. PaiMZwerlingAMenziesD
2008
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection—An update.
Ann Intern Med
149
177
184
38. LingDIZwerlingAPaiM
2008
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis.
Eur Respir J
E-pub 9 July 2008. doi:10.1183/09031936.00061808
39. AndersenPDohertyTMPaiMWeldinghK
2007
The prognosis of latent tuberculosis: Can disease be predicted.
Trends Mol Med
13
175
182
40. TrajmanAPaiMDhedaKvan zyl SmitRZwerlingA
2008
Novel tests for diagnosing tuberculous pleural effusion: What works and what does not.
Eur Respir J
31
1098
1106
41. World Health Organization
2007
The global MDR-TB and XDR-TB response plan 2007–2008.
Available: http://whqlibdoc.who.int/hq/2007/WHO_HTM_TB_2007.387_eng.pdf. Accessed 16 June 2008
42. HopewellPCPaiMMaherDUplekarMRaviglioneMC
2006
International standards for tuberculosis care.
Lancet Infect Dis
6
710
725
43. GetahunHHarringtonMO'BrienRNunnP
2007
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes.
Lancet
369
2042
2049
44. World Health Organization
2007
Reduction of number of smears for the diagnosis of pulmonary TB.
Available: http://www.who.int/tb/dots/laboratory/policy/en/index2.html. Accessed 16 June 2008
45. World Health Organization
2007
Definition of a new sputum smear-positive TB case.
Available: http://www.who.int/tb/dots/laboratory/policy/en/index1.html. Accessed 16 June 2008
46. SquireSBBelayeAKKashotiASalaniponiFMMundyCJ
2005
‘Lost’ smear-positive pulmonary tuberculosis cases: Where are they and why did we lose them.
Int J Tuberc Lung Dis
9
25
31
47. World Health Organization
2007
The use of liquid medium for culture and DST.
Available: http://www.who.int/tb/dots/laboratory/policy/en/index3.html. Accessed 16 June 2008
48. RidderhofJCvan DeunAKamKMNarayananPRAzizMA
2007
Roles of laboratories and laboratory systems in effective tuberculosis programmes.
Bull World Health Organ
85
354
359
49. World Health Organization, Special Programme for Research and Training in Tropical Diseases
2006
Request for applications: Diagnostic trial sites: Improving the diagnosis of tuberculosis through optimization of sputum smear microscopy.
Available: http://www.who.int/tdr/grants/grants/trial_sites.htm. Accessed 16 June 2008
50. Foundation for Innovative New Diagnostics
2008
Market launch of improved fluorescence microscope scheduled for later this year.
Available: http://www.finddiagnostics.org/news/press/zeiss_mar08.pdf. Accessed 16 June 2008
51. CunninghamJ
2005
Rapid serological-based TB test evaluation: Prelim analysis. Stop TB Working Group on New Diagnostics.
Available: http://www.stoptb.org/wg/new_diagnostics/assets/documents/jane_cunningham.pdf. Accessed 16 June 2008
52. PerkinsMDCunninghamJ
2007
Facing the crisis: Improving the diagnosis of tuberculosis in the HIV era.
J Infect Dis
196
Suppl 1
S15
S27
53. Canadian Tuberculosis Committee
2007
Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS).
Can Commun Dis Rep
33
1
18
54. HPA Tuberculosis Programme Board
2007
Health Protection Agency Position Statement on the use of Interferon Gamma Release Assay (IGRA) tests for tuberculosis (TB): Draft for consultation.
Available: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1204186168242. Accessed 16 June 2008
55. National Tuberculosis Advisory Committee Australia
2007
Position statement on interferon-gamma release immunoassays in the detection of latent tuberculosis infection, October 2007.
Commun Dis Intell
31
404
405
56. PaiMDhedaKCunninghamJScanoFO'BrienR
2007
T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward.
Lancet Infect Dis
7
428
438
57. PaiMO'BrienR
2006
Tuberculosis diagnostics trials: Do they lack methodological rigor.
Expert Rev Mol Diagn
6
509
514
58. SmallPMPerkinsMD
2000
More rigour needed in trials of new diagnostic agents for tuberculosis.
Lancet
356
1048
1049
59. BanooSBellDBossuytPHerringAMabeyD
2006
Evaluation of diagnostic tests for infectious diseases: General principles.
Nat Rev Microbiol
4
S21
S31
60. BossuytPMReitsmaJBBrunsDEGatsonisCAGlasziouPP
2003
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Ann Intern Med
138
40
44
61. SchünemannHJOxmanADBrozekJGlasziouPJaeschkeR
2008
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.
BMJ
336
1106
1110
62. Stop TB Partnership Working Group on New TB Diagnostics
2007
Revised strategic plan of the Stop TB Partnership's Working Group on New Diagnostics.
Available: http://www.stoptb.org/wg/new_diagnostics/assets/documents/Draft%20NDWG%20Strategic%20Plan%20for%20Cape%20Town%20Meeting.pdf. Accessed 16 June 2008
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2008 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Evidence-Based Tuberculosis Diagnosis
- Organophosphate Poisoning–Induced Intermediate Syndrome: Can Electrophysiological Changes Help Predict Outcome?
- The Effects of International Monetary Fund Loans on Health Outcomes
- Next Stop, Don't Block the Doors: Opening Up Access to Clinical Trials Results